e-learning
resources
Amsterdam 2011
Monday, 26.09.2011
Aetiology, diagnosis and outcomes in community-acquired pneumonia
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
A worldwide perspective of nursing home pneumonia beside community acquired pneumonia
A. Liapikou, E. Polverino, C. Cilloniz, P. Peyrani, J. Ramirez, R. Menendez, A. Torres (Athens, Greece; Barcelona, Spain; Louisville, United States Of America)
Source:
Annual Congress 2011 - Aetiology, diagnosis and outcomes in community-acquired pneumonia
Session:
Aetiology, diagnosis and outcomes in community-acquired pneumonia
Session type:
Thematic Poster Session
Number:
2466
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Liapikou, E. Polverino, C. Cilloniz, P. Peyrani, J. Ramirez, R. Menendez, A. Torres (Athens, Greece; Barcelona, Spain; Louisville, United States Of America). A worldwide perspective of nursing home pneumonia beside community acquired pneumonia. Eur Respir J 2011; 38: Suppl. 55, 2466
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
A prospective comparison of nursing home acquired pneumonia with community acquired pneumonia
Source: Eur Respir J 2001; 18: 362-368
Year: 2001
Respiratory rate recording by medical and nursing staff in community acquired pneumonia
Source: Eur Respir J 2004; 24: Suppl. 48, 51s
Year: 2004
Epidemiology, antimicrobial resistance and clinical outcomes in nursing home associated pneumonia compared to community acquired pneumonia
Source: Annual Congress 2013 –Antibiotics, resistance and vaccines
Year: 2013
Determinants of hospital costs in community acquired pneumonia
Source: Annual Congress 2012 - Management of pneumonia due to hospital pathogens
Year: 2012
Actual problem in childhood - community acquired pneumonia
Source: Eur Respir J 2005; 26: Suppl. 49, 167s
Year: 2005
Management of community acquired pneumonia audit
Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia
Year: 2009
Management of community acquired pneumonia
Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests
Year: 2008
Management of community acquired pneumonia
Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations
Year: 2010
Healthcare-associated pneumonia among hospitalized patients. Is it really different from community acquired pneumonia?
Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections
Year: 2012
Fusing ICU clinical care and clinical research in severe community acquired pneumonia
Source: International Congress 2016 – PG16 Infection control in epidemics: strengthening the evidence base for healthcare workers and the public
Year: 2016
Community-acquired pneumonia as an emergency: time for an aggressive intervention to lower mortality
Source: Eur Respir J 2011; 38: 253-260
Year: 2011
Implementing a community acquired pneumonia care bundle in the acute hospital setting
Source: Annual Congress 2011 - The new clinical spectrum of lung diseases: from bronchi to pleura
Year: 2011
Temporal trends in community acquired pneumonia in two Canadian teaching hospitals
Source: Eur Respir J 2003; 22: Suppl. 45, 150s
Year: 2003
Consequences of community acquired pneumonia requiring admission to hospital in childhood
Source: Eur Respir J 2004; 24: Suppl. 48, 171s
Year: 2004
A prospective comparison of nursing home acquired pneumonia (NAP) with community acquired pneumonia (CAP)
Source: Eur Respir J 2005; 26: Suppl. 49, 257s
Year: 2005
The general evaluation of elderly patients with community acquired pneumonia
Source: Eur Respir J 2004; 24: Suppl. 48, 412s
Year: 2004
Risk factors for immunosuppression in hospitalized patients coming from the community with pneumonia: a worldwide perspective
Source: International Congress 2018 – Improving the outcomes of community-acquired pneumonia
Year: 2018
Factors associated with mortality in community acquired pneumonia at a tertiary care hospital in Pakistan
Source: Eur Respir J 2005; 26: Suppl. 49, 643s
Year: 2005
Health care associated pneumonia (HCAP) and community acquired pneumonia (CAP): Are they different diseases?
Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept